Sean F. Scanlan - 18 Jul 2025 Form 4 Insider Report for TREACE MEDICAL CONCEPTS, INC. (TMCI)

Role
Chief Innovation Officer
Signature
/s/ Lisa Taylor as Attorney-in-fact for Sean Scanlan
Issuer symbol
TMCI
Transactions as of
18 Jul 2025
Net transactions value
+$24,001
Form type
4
Filing time
22 Jul 2025, 17:00:09 UTC
Previous filing
19 Mar 2025
Next filing
12 Aug 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Scanlan Sean F. Chief Innovation Officer C/O TREACE MEDICAL CONCEPTS, INC., 100 PALMETTO PARK PLACE, PONTE VEDRA /s/ Lisa Taylor as Attorney-in-fact for Sean Scanlan 21 Jul 2025 0001856371

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction TMCI Common Stock Options Exercise $24,001 +33,437 +9.5% $0.7178 383,621 18 Jul 2025 Direct F1, F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction TMCI Stock Option (Right to Buy) Options Exercise $0 -33,437 -100% $0.000000 0 18 Jul 2025 Common Stock 33,437 $0.7178 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Includes 325,098 restricted stock units.
F2 Reflects the transfer of 13,897 shares of common stock to the reporting person's former spouse pursuant to a domestic relations order.
F3 The stock option vested in equal annual installments over 4 years, commencing on July 28, 2015 with the last installment vesting on July 28, 2019.